Endogenously produced factor XI (FXI) contributes to hepatic cancer cell-induced coagulation activation

L Beckmann, K Riecken, J Mäder, C Rolling… - …, 2024 - thieme-connect.com
Method Several cancer cell lines were characterized for FXI and tissue factor (TF)
expression by quantitative PCR, ELISA and flow cytometry. FXI activity was recorded by a …

Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

M Di Nisio, M Candeloro, N Potere, E Porreca… - … and Vascular Biology, 2024 - btvb.org
Venous thromboembolism (VTE) is a relatively common complication in cancer patients with
potentially dire consequences. Anticoagulants are the mainstay of treatment of cancer …

[PDF][PDF] THESIS/THÈSE

C FIGULA - pure.unamur.be
L'utilisation d'anticoagulant est très fréquente étant donné que la fréquence d'apparition de
thrombo-embolie veineuse (TEV) est de 1 à 2 cas pour 1000 personnes par an et que la …